CEMIPLIMAB-RWLC

2083 reported adverse events

These side effects are most commonly reported by patients taking CEMIPLIMAB-RWLC:

# Side effect Count
0 DEATH 176
1 DISEASE PROGRESSION 155
2 OFF LABEL USE 107
3 FATIGUE 88
4 RASH 86
5 DYSPNOEA 65
6 PYREXIA 64
7 PRURITUS 53
8 INTERSTITIAL LUNG DISEASE 50
9 MYOCARDITIS 50
See all common reactions for CEMIPLIMAB-RWLC

CEMIPLIMAB-RWLC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CORNEAL DIAMETER INCREASED 1 0.2500
1 3M SYNDROME 2 0.1538
2 SQUAMOUS CELL CARCINOMA ANTIGEN INCREASED 2 0.1429
3 BASAL CELL CARCINOMA METASTATIC 2 0.1176
4 TUMOUR EXUDATION 2 0.0606
5 ANGIOTENSIN CONVERTING ENZYME DECREASED 1 0.0588
6 DIFFUSE UVEAL MELANOCYTIC PROLIFERATION 1 0.0526
7 ENCEPHALITIS ALLERGIC 1 0.0526
8 DELAYED ISCHAEMIC NEUROLOGICAL DEFICIT 1 0.0476
9 SKIN SQUAMOUS CELL CARCINOMA METASTATIC 4 0.0421
See all enriched reactions for CEMIPLIMAB-RWLC